# Abbott Laboratories (ABT) — Q1-2024 Earnings Results

**Report date:** 2024-04-17 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q1-2024

## Post-Earnings Brief

### Headline

Abbott Laboratories Beats on EPS, Stock Down 3.03%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.98 | N/A | +2.62% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based solely on numerical results.

### Guidance Changes

No guidance data is available.

### What It Means

Abbott Laboratories reported an EPS of $0.98, slightly beating expectations. However, the stock fell by 3.03% following the earnings release, indicating that investors may have had concerns despite the EPS beat. Without additional context from management commentary or guidance, the market's reaction reflects uncertainty about the company's future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q1-2024_